Pfizer says money killed AZ deal

Share this article:

Pfizer Chief Financial Officer Frank D'Amelio told an audience at a Goldman Sachs investment conference that the AstraZeneca deal fell apart over money, Bloomberg reports.

AstraZeneca turned down the $117 billion bid Memorial Day weekend, and Pfizer cannot approach the company until three months have lapsed.

Bloomberg reported earlier that perceived personal affronts also doomed Pfizer's overture.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.